Celebrating Milestones: Mimesis at the In Silico World Final Event, VPH2024

The In Silico World final event at the VPH2024 conference in Stuttgart was a landmark occasion, and the Mimesis group is thrilled to have been a key part of this groundbreaking event. With over 180 participants joining us both in person and virtually, the event provided a valuable platform to celebrate the advancements in #InSilicoMedicine …

Mimesis S.r.l. Celebra il Successo al 🌟 Piaceri Day 2024 🌟

Ieri, 11 luglio 2024, si Γ¨ tenuto l’evento 🌟 𝐏𝐒𝐚𝐜𝐞𝐫𝐒 πƒπšπ² πŸπŸŽπŸπŸ’ 🌟, una giornata dedicata alla ricerca promossa dall’UniversitΓ  degli Studi di Catania (UNICT). Questo evento ha rappresentato una straordinaria opportunitΓ  per Mimesis S.r.l. e il nostro team di ricerca di condividere il nostro lavoro innovativo e i progressi compiuti nell’ambito delle simulazioni in …

Webinar: Empowering Ethical and Efficient Drug Development through Advanced Computational

Yesterday, members of Avicenna Alliance were treated to an exclusive webinar that promised to reshape the landscape of drug development. Titled “Empowering Ethical and Efficient Drug Development through Advanced Computational,” the webinar featured Martina Di Salvatore from Mimesis SRL as the keynote speaker. Taking place on Tuesday, May 7th, 2024, at 5:00 pm CET, the …

Featured on #UnictMagazine by #Unict: Breakthrough Research on the #JollyVaccine!

We’re excited to share that our research team at the University of Catania is front and center in #UnictMagazine with our latest groundbreaking study on the #JollyVaccine! In this pioneering investigation, we’ve dedicated ourselves to crafting an innovative solution to address the complexities surrounding vaccination, specifically focusing on the concept of a “Jolly Vaccine.” This …

UISS: Revolutionizing In Silico Simulation – A Roundup of Recent Recognition

In the dynamic realm of medical research and technology, breakthroughs often fly under the radar until they gain widespread acclaim. However, for the Universal Immune System Simulator (UISS), created by Professor Francesco Pappalardo and his team, recognition has recently poured in from seven prestigious newspapers. This marks a pivotal moment not only for the UISS …

Advancing Medicine: Insights from the Workshop on Regulatory Barriers to In Silico Trials in Catania

Nestled within the historic Monastero dei Benedettini in Catania, the annual Workshop on Regulatory Barriers to In Silico Trials convened on March 14-15, drawing together key figures and enthusiasts from the In Silico community. This gathering provided a unique opportunity to delve into the intricate challenges surrounding the integration of simulation technologies in medical practices. …

laboratory 563423 1920

Double Feature: Highlighted Twice in Unict Magazine!

We are delighted to share with you an exciting update: our endeavors have been spotlighted not once, but twice in the esteemed pages of Unict magazine! Article #1: Delve into an exploration of Mimesis. From its conceptualization to its present iteration, uncover how innovation drives our progress. Article #2: Prepare for a momentous revelation! We …

AI ROSSO faccia con codice binario

Pioneering the Future of Healthcare: Mimesis S.r.l. and the Universal Impact of Regulatory Support

Advancing Towards Regulatory Recognition: Mimesis S.r.l.’s Groundbreaking Effort In a world-first, Mimesis S.r.l., within the innovative In Silico World (ISW) Consortium (https://www.insilico.world), has secured preliminary regulatory acceptance from the European Medicine Agency (EMA) for its UISS-TB-DR simulation platform. This groundbreaking achievement not only marks a historic moment for tuberculosis (TB) vaccine development but also opens …

Mimesis attended the “Giornata di Orientamento al lavoro e alle professioni”

We are thrilled to share the exciting news that our team was honored with an invitation to step inside the hallowed halls of the Faculty of Mathematics and Informatics at Unict. The purpose? To present Mimesis to a vibrant audience of young students and graduates eager to explore the frontiers of technology and innovation. 🀝 …